Epoqe Pharma ApS: Financial statements 2025
CVR: 42443670
Source: annual report 2025, Danish Business Authority
01/07/2024 – 30/06/2025
Epoqe Pharma ApS (CVR 42443670) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK -13,719,778 and a net result of DKK -13,943,884 compared with DKK -135,919 the year before. Equity in the 2025 report amounted to DKK 30,042,156. The solvency ratio was 86.2%. The company had 3 employees in the financial year.
- Gross Profit
- DKK -13,719,778
- Profit/Loss
- DKK -13,943,884
- Equity
- DKK 30,042,156
- Total Assets
- DKK 34,850,599
- Employees
- 3
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2025 | - | -13.7 mio. | -13.9 mio. | 30 mio. | 3 |
| 2024 | - | 1.3 mio. | -136 t. | -18 t. | 2 |
| 2023 | - | -19 t. | -15 t. | 118 t. | - |
| 2022 | - | -17 t. | -18 t. | 133 t. | - |
Official annual report
How creditworthy is Epoqe Pharma ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2025
As of July 31, 2025, Jens Thostrup Bukrinski has stepped down as director of Epoqe Pharma ApS.
As of January 9, 2025, Anders Gaarsdal Holst has joined the board of directors of Epoqe Pharma ApS.
As of January 9, 2025, Henrijette Elsebeth Richter has joined the board of directors of Epoqe Pharma ApS.
As of January 9, 2025, Lars Gredsted has joined the board of directors of Epoqe Pharma ApS.
As of January 8, 2025, Anders Gaarsdal Holst has left the board of directors of Epoqe Pharma ApS.
As of January 8, 2025, Henrijette Elsebeth Richter has left the board of directors of Epoqe Pharma ApS.
About Epoqe Pharma ApS
Epoqe Pharma ApS is a Danish company of the type Anpartsselskab based in Frederiksberg, founded in 2021. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named Patentselskabet af 31. maj 2021 ApS.. The management consists of Mark Stephen Sumeray. The board consists of Anders Gaarsdal Holst (chair), Henrijette Elsebeth Richter, Lars Gredsted and Mark Stephen Sumeray. The company's owners include LUNDBECKFOND INVEST A/S, Helms & Sams ApS and CMCGreenhouse ApS. The company has 5 employees (2026). In 2025, the company reported a gross profit of DKK -13,719,778 and a net result of DKK -13,943,884 compared with DKK -135,919 the year before. Equity in the 2025 report amounted to DKK 30,042,156.